2.69
前日終値:
$2.61
開ける:
$2.56
24時間の取引高:
1.63M
Relative Volume:
0.69
時価総額:
$435.67M
収益:
$25.55M
当期純損益:
$-341.97M
株価収益率:
-0.9607
EPS:
-2.8
ネットキャッシュフロー:
$-304.44M
1週間 パフォーマンス:
+21.17%
1か月 パフォーマンス:
-23.36%
6か月 パフォーマンス:
-59.49%
1年 パフォーマンス:
-56.68%
Relay Therapeutics Inc Stock (RLAY) Company Profile
RLAY を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
RLAY
Relay Therapeutics Inc
|
2.69 | 435.67M | 25.55M | -341.97M | -304.44M | -2.80 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-09-10 | 再開されました | Goldman | Buy |
2024-09-10 | アップグレード | Jefferies | Hold → Buy |
2024-09-10 | ダウングレード | Oppenheimer | Outperform → Perform |
2024-05-10 | アップグレード | Barclays | Equal Weight → Overweight |
2023-04-20 | アップグレード | Jefferies | Underperform → Hold |
2023-04-19 | アップグレード | Raymond James | Outperform → Strong Buy |
2023-04-13 | 開始されました | Raymond James | Outperform |
2023-02-03 | 開始されました | Oppenheimer | Outperform |
2022-09-30 | 開始されました | Barclays | Equal Weight |
2022-09-02 | 開始されました | Stifel | Buy |
2022-06-06 | 開始されました | Jefferies | Underperform |
2022-02-01 | 開始されました | Berenberg | Buy |
2021-07-21 | 開始されました | BofA Securities | Buy |
2020-12-15 | 繰り返されました | H.C. Wainwright | Buy |
2020-12-08 | 開始されました | JMP Securities | Mkt Outperform |
2020-11-05 | 開始されました | H.C. Wainwright | Buy |
2020-08-10 | 開始されました | Cowen | Outperform |
2020-08-10 | 開始されました | Goldman | Buy |
2020-08-10 | 開始されました | Guggenheim | Buy |
2020-08-10 | 開始されました | JP Morgan | Neutral |
すべてを表示
Relay Therapeutics Inc (RLAY) 最新ニュース
Wells Fargo & Company Begins Coverage on Relay Therapeutics (NASDAQ:RLAY) - Defense World
Wells Fargo Initiates Coverage of Relay Therapeutics (RLAY) with Equal-Weight Recommendation - Nasdaq
This Twin Disc Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Wells Fargo Initiates Relay Therapeutics at Equalweight With $4 Price Target - marketscreener.com
Relay Therapeutics (RLAY) Assigned Equal Weight by Wells Fargo | RLAY Stock News - GuruFocus
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Is Relay Therapeutics Inc. (NASDAQ:RLAY) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Top Cancer Stocks to Buy to Boost Your Portfolio's Health - Yahoo Finance
Relay Therapeutics: Trying To Find That Right Price - Seeking Alpha
Corebridge Financial Inc. Acquires 7,314 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Vanguard Group Inc. Acquires 566,595 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics Inc (NASDAQ: RLAY): Blank Check On Growth? - stocksregister.com
KLP Kapitalforvaltning AS Purchases New Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
American Century Companies Inc. Buys 51,499 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (RLAY): Among Stocks Under $10 that Will Triple - Insider Monkey
10 Stocks Under $10 that Will Triple - Insider Monkey
Norges Bank Takes $23.82 Million Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Raymond James Financial Inc. Invests $779,000 in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Cancer drug developer cuts staff for the third time in a year - The Business Journals
Relay Therapeutics Inc (RLAY) Recovers -2.97% From Low: Are We There Yet? - stocksregister.com
Thrivent Financial for Lutherans Grows Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Teacher Retirement System of Texas Purchases 5,492 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics stock hits 52-week low at $2.44 - Investing.com India
Relay Therapeutics stock hits 52-week low at $2.44 By Investing.com - Investing.com UK
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Virtu Financial LLC - Defense World
Relay Therapeutics’ SWOT analysis: promising drug data boosts stock outlook - Investing.com Australia
Relay Therapeutics’ SWOT analysis: promising drug data boosts stock outlook By Investing.com - Investing.com UK
Relay Therapeutics (RLAY) Gets Analyst Boost as AI-Driven Drug Discovery Shines! - Insider Monkey
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Purchased by HighTower Advisors LLC - Defense World
Charles Schwab Investment Management Inc. Decreases Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Relay Therapeutics stock hits 52-week low at $3.01 amid market challenges By Investing.com - Investing.com South Africa
Relay Therapeutics stock hits 52-week low at $3.01 amid market challenges - Investing.com India
Bank of New York Mellon Corp Buys 50,190 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Investor Alert: What’s Really Going On At Relay Therapeutics Inc (NASDAQ: RLAY) - Stocks Register
Victory Capital Management Inc. Has $63,000 Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Steward Partners Investment Advisory LLC Purchases 4,000 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Head-To-Head Contrast: Relay Therapeutics (NASDAQ:RLAY) & Kyverna Therapeutics (NASDAQ:KYTX) - Defense World
Relay Therapeutics’ SWOT analysis: promising drug faces stiff competition By Investing.com - Investing.com South Africa
Relay Therapeutics’ SWOT analysis: promising drug faces stiff competition - Investing.com India
Arizona State Retirement System Acquires 7,547 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics Inc (RLAY) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):